Overview

* Global Medical REIT ( GMRE ) Q3 rental revenue grows 8.4% yr/yr, driven by acquisitions

* Company reports Q3 net loss due to $6.3 mln impairment charge on Aurora facility

* Global Medical REIT ( GMRE ) establishes $50 mln share repurchase program, no shares repurchased yet

Outlook

* Company narrows full-year 2025 AFFO guidance to $4.50-$4.60 per share and unit

* Company assumes no additional acquisitions or dispositions for 2025 guidance

* Company expects no further equity or debt issuances beyond normal revolver activity

Result Drivers

* ACQUISITIONS DRIVE REVENUE - Rental revenue increased by 8.4% yr/yr, primarily due to acquisitions completed after September 2024

* IMPAIRMENT CHARGE - $6.3 mln impairment charge on Aurora facility contributed to net loss

* DISPOSITIONS - Completed two property sales, generating $3.8 mln in proceeds

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $37.03

Rental mln

Revenue

Q3 Net -$5.05

Income mln

Q3 $16.24

Adjusted mln

FFO

Q3 FFO $14.53

mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the specialized reits peer group is "buy"

* Wall Street's median 12-month price target for Global Medical REIT Inc ( GMRE ) is $41.75, about 27% above its November 3 closing price of $30.46

* The stock recently traded at 150 times the next 12-month earnings vs. a P/E of 50 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)